Aerosol Therapy Market Size Estimated to Observe Significant Growth by 2024

Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/aerosol-therapy-market.asp

This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.

Aerosol therapy provides a fast and non-invasive way for treatment of lung disorders as the drug is delivered at the receptor site. Effectiveness of the therapy depends on how deeply aerosol particles infiltrate into the bronchial track and where the particles are deposited. A particle size under 2μm is ideal and can permeate up to the peripheral airways. That is why most commercially available aerosol devices produce droplets of roughly this size.

As per the World Health Organization, about half the cases of asthma and COPD are due to hereditary weakness and the other cases are due to environmental factors. The effect of pollution is likely to intensify globally along with industrialization of areas, and increasing the number of vehicles. Current government activities and rising healthcare investments are drivers of aerosol therapy market, which would upgrade over the examination time frame. Increasing prices are major factor that is restraining the growth of the market in terms of value.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11944

The global market for aerosol therapy is segmented on the basis of product type, technology, disease indication, end user and geography:

• Segmentation by product type:
  
  
  
  • Inhalers
    
    
    
    • Dry Powder Inhalers (DPIs)
    
    
    • Metered Dose Inhalers (MDIs)
    
    
    
    
  
  
  • Nebulizers
    
    
    
    • Ultrasonic Nebulizer
    
    
    • Compressed Air-Jet nebulizers
    
    
    • Vibrating membrane device
    
    
    
    
  
  
  • Bronchodilators
  
  
  
  


• Segmentation by technology:
  
  
  
  • Manually operated
  
  
  • Digitally operated
  
  
  
  


• Segmentation by disease indication:
  
  
  
  • Asthma
  
  
  • COPD
  
  
  • BPD
  
  
  • Other
  
  
  
  


• Segmentation by end user:
  
  
  
  • Hospitals
  
  
  • Clinics
  
  
  • Ambulatory Surgical Centers
  
  
  • Individual